Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

Direct Payment

$120,000.00

A Rapid, Culture-Free Diagnostic Platform for Sepsis Using Density-Shift Immunocapture Separation and Machine-Learning Powered Raman Spectroscopy

EF 2025-26

Résumé
Sepsis is a life-threatening condition that occurs when the body's response to a bacterial infection entering the blood becomes uncontrolled, leading to multiple organ failure and death. It is a global health emergency that affects 49 million people globally every year and causes 11 million deaths, including 3.4 million children under five. It causes 1 in 18 deaths in Canada and a third of all hospital-related deaths in the US. Quick and accurate diagnosis is critical because every hour of delay in treatment increases risk of death by 7%. Current diagnostic tests, such as blood cultures, are slow, unreliable, and fail to identify viable disease pathogens or inform antimicrobial susceptibility in real time. There remains an urgent unmet need for a rapid test that can detect infection directly from a blood sample without waiting for lab cultures, even at low bacterial concentrations. This project aims to develop a rapid, precise diagnostic test for sepsis that can detect bacteria directly from blood within 2 hours. The approach combines an innovative separation technique that isolates bacteria from blood using specialized microbeads with a laser-based method called Raman spectroscopy, which captures a bacterium's unique molecular "fingerprint." Machine learning algorithms will then analyze these patterns to identify infection and predict its resistance to antibiotics without the need for long lab processing. By enabling earlier and more accurate diagnosis of sepsis, this technology could help doctors begin the right treatment sooner, saving lives and reducing antibiotics misuse that contributes to growing antibiotic resistance. With the long-term goal of integrating this technology into a compact, portable device, we also aim to improve access to life-saving diagnostics in rural and resource-limited areas. Ultimately, this research will strengthen Canada's healthcare system, support personalized healthcare, and reduce infection-related illness and deaths worldwide.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
556151
Name
Badawy Seleem W
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
A Rapid, Culture-Free Diagnostic Platform for Sepsis Using Density-Shift Immunocapture Separation and Machine-Learning Powered Raman Spectroscopy
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Bacteria; Biophotonics; Clinically Translational Bioengineering; Diagnostics; Immunocapture Separation; Machine Learning; Optical Biosensing; Pathogen Detection; Raman Spectroscopy; Sepsis
Abstract
Sepsis is a life-threatening condition that occurs when the body's response to a bacterial infection entering the blood becomes uncontrolled, leading to multiple organ failure and death. It is a global health emergency that affects 49 million people globally every year and causes 11 million deaths, including 3.4 million children under five. It causes 1 in 18 deaths in Canada and a third of all hospital-related deaths in the US. Quick and accurate diagnosis is critical because every hour of delay in treatment increases risk of death by 7%. Current diagnostic tests, such as blood cultures, are slow, unreliable, and fail to identify viable disease pathogens or inform antimicrobial susceptibility in real time. There remains an urgent unmet need for a rapid test that can detect infection directly from a blood sample without waiting for lab cultures, even at low bacterial concentrations. This project aims to develop a rapid, precise diagnostic test for sepsis that can detect bacteria directly from blood within 2 hours. The approach combines an innovative separation technique that isolates bacteria from blood using specialized microbeads with a laser-based method called Raman spectroscopy, which captures a bacterium's unique molecular "fingerprint." Machine learning algorithms will then analyze these patterns to identify infection and predict its resistance to antibiotics without the need for long lab processing. By enabling earlier and more accurate diagnosis of sepsis, this technology could help doctors begin the right treatment sooner, saving lives and reducing antibiotics misuse that contributes to growing antibiotic resistance. With the long-term goal of integrating this technology into a compact, portable device, we also aim to improve access to life-saving diagnostics in rural and resource-limited areas. Ultimately, this research will strengthen Canada's healthcare system, support personalized healthcare, and reduce infection-related illness and deaths worldwide.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Badawy, Seleem W
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~